Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 1
2021 2
2022 3
2023 3
2024 4
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean orth r (159 results)?
Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E, Lacombe V, Terriou L, Ardois S, Bouaziz JD, Mathian A, Le Guenno G, Aouba A, Outh R, Meyer A, Roux-Sauvat M, Ebbo M, Zhao LP, Bigot A, Jamilloux Y, Guillotin V, Flamarion E, Henneton P, Vial G, Jachiet V, Rossignol J, Vinzio S, Weitten T, Vinit J, Deligny C, Humbert S, Samson M, Magy-Bertrand N, Moulinet T, Bourguiba R, Hanslik T, Bachmeyer C, Sebert M, Kostine M, Bienvenu B, Biscay P, Liozon E, Sailler L, Chasset F, Audemard-Verger A, Duroyon E, Sarrabay G, Borlot F, Dieval C, Cluzeau T, Marianetti P, Lobbes H, Boursier G, Gerfaud-Valentin M, Jeannel J, Servettaz A, Audia S, Larue M, Henriot B, Faucher B, Graveleau J, de Sainte Marie B, Galland J, Bouillet L, Arnaud C, Ades L, Carrat F, Hirsch P, Fenaux P, Fain O, Sujobert P, Kosmider O, Mekinian A; French VEXAS group; GFEV, GFM, CEREMAIA, MINHEMON. Georgin-Lavialle S, et al. Among authors: outh r. Br J Dermatol. 2022 Mar;186(3):564-574. doi: 10.1111/bjd.20805. Epub 2021 Nov 28. Br J Dermatol. 2022. PMID: 34632574 Free article.
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.
Kosmider O, Possémé C, Templé M, Corneau A, Carbone F, Duroyon E, Breillat P, Chirayath TW, Oules B, Sohier P, Luka M, Gobeaux C, Lazaro E, Outh R, Le Guenno G, Lifermann F, Berleur M, Le Mene M, Friedrich C, Lenormand C, Weitten T, Guillotin V, Burroni B, Boussier J, Willems L, Aractingi S, Dionet L, Tharaux PL, Vergier B, Raynaud P, Ea HK, Ménager M, Duffy D, Terrier B. Kosmider O, et al. Among authors: outh r. Nat Commun. 2024 Jan 30;15(1):910. doi: 10.1038/s41467-024-44811-4. Nat Commun. 2024. PMID: 38291039 Free PMC article.
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.
Hadjadj J, Nguyen Y, Mouloudj D, Bourguiba R, Heiblig M, Aloui H, McAvoy C, Lacombe V, Ardois S, Campochiaro C, Maria A, Coustal C, Comont T, Lazaro E, Lifermann F, Le Guenno G, Lobbes H, Grobost V, Outh R, Campagne J, Dor-Etienne A, Garnier A, Jamilloux Y, Dossier A, Samson M, Audia S, Nicolas B, Mathian A, de Maleprade B, De Sainte-Marie B, Faucher B, Bouaziz JD, Broner J, Dumain C, Antoine C, Carpentier B, Castel B, Lartigau-Roussin C, Crickx E, Volle G, Fayard D, Decker P, Moulinet T, Dumont A, Nguyen A, Aouba A, Martellosio JP, Levavasseur M, Puigrenier S, Antoine P, Giraud JT, Hermine O, Lacout C, Martis N, Karam JD, Chasset F, Arnaud L, Marianetti P, Deligny C, Chazal T, Woaye-Hune P, Roux-Sauvat M, Meyer A, Sujobert P, Hirsch P, Abisror N, Fenaux P, Kosmider O, Jachiet V, Fain O, Terrier B, Mekinian A, Georgin-Lavialle S; FRENVEX. Hadjadj J, et al. Among authors: outh r. Ann Rheum Dis. 2024 Sep 30;83(10):1358-1367. doi: 10.1136/ard-2024-225640. Ann Rheum Dis. 2024. PMID: 38777378
Nonischemic Cardiac Manifestations in VEXAS Syndrome.
Robert M, Mathian A, Lacombe V, Lobbes H, Adélaïde L, Le Besnerais M, Dacher JN, Terrier B, Mékinian A, Bourguiba R, Georgin-Lavialle S; FRENVEX Group. Robert M, et al. JAMA Netw Open. 2024 Dec 2;7(12):e2450251. doi: 10.1001/jamanetworkopen.2024.50251. JAMA Netw Open. 2024. PMID: 39666342 Free PMC article.
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.
Jachiet V, Kosmider O, Beydon M, Hadjadj J, Zhao LP, Grobost V, Lacombe V, Le Guenno G, Nguyen Y, Arlet JB, Dion J, Heiblig M, Garnier A, Samson M, Aouba A, Thépot S, Dimicoli-Salazar S, Dutasta F, Faucher B, Lazaro E, Morel V, Néel A, Outh R, Bezanahary H, Rossignol J, Alary AS, Bidet A, Blateau P, Bouvier A, Boursier G, Decamp M, Lebecque B, Le Bris Y, Sujobert P, Marceau-Renaut A, Pastoret C, Rizzo D, Boiret-Dupré N, Boucher L, Dulucq S, Genevieve F, Jadeau C, Lemaire P, Vazquez R, Rieu JB, Fain O, Georgin-Lavialle S, Rigolot L, Larcher L, Hirsch P, Terrier B, Fenaux P, Mékinian A, Comont T. Jachiet V, et al. Among authors: outh r. Blood. 2025 Sep 18;146(12):1450-1461. doi: 10.1182/blood.2024028133. Blood. 2025. PMID: 40373272
Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis.
Nagle S, Nguyen Y, Guerry MJ, Quemeneur T, Titeca-Beauport D, Crépin T, Mesbah R, Boudhabhay I, Pugnet G, Lebas C, Néel A, Karras A, Hachulla E, Woessner J, Pestre V, Borie R, Vinzio S, Gouin JB, Melboucy-Belkhir S, Outh R, Subran B, Gerfaud-Valentin M, Humbert S, Kerschen P, Uzunhan Y, Goulenok T, Beydon M, Costedoat-Chalumeau N, Puechal X, Terrier B. Nagle S, et al. Among authors: outh r. Ann Rheum Dis. 2025 Feb;84(2):319-328. doi: 10.1136/ard-2024-226339. Epub 2025 Jan 2. Ann Rheum Dis. 2025. PMID: 39919904
Neurological manifestations in patients with VEXAS syndrome.
Bert-Marcaz C, Fortanier É, Briantais A, Faucher B, Bourguiba R, Swiader L, Schleinitz N, Corazza G, Jean R, Bigot A, Marianetti-Guingel P, Kostine M, Outh R, Dieudonné Y, Lazaro E, Vial G, Palat S, Frachet S, De Almeida Chaves S, Vinzio S, Sacré K, Robert M, Comont T, Dion J, Girardie P, Lacombe V, Langlois V, Jachiet V, Decker P, Moulinet T, Grosleron S, Broner J, Guilpain P, Samson M, Terrier B, Georgin-Lavialle S, Attarian S, Mekinian A, Delmont E, Ebbo M; FRENVEX; MINHEMON; FILNEMUS. Bert-Marcaz C, et al. Among authors: outh r. J Neurol. 2025 Feb 1;272(2):181. doi: 10.1007/s00415-025-12902-x. J Neurol. 2025. PMID: 39891740
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases.
Zakine È, Papageorgiou L, Bourguiba R, Mekinian A, Terrier B, Kosmider O, Hirsch P, Jachiet M, Audia S, Ardois S, Adélaïde L, Bigot A, Duriez P, Emile JF, Lazaro E, Fayard D, Galland J, Hié M, Humbert S, Jean A, Kostine M, Lacombe V, Le Guenno G, Lobbes H, Magy-Bertrand N, Marianetti-Guingel P, Mathian A, Outh R, Saillard C, Samson M, Vial G, Bouaziz JD, Moguelet P, Chasset F; National French VEXAS Study Group (NFVS). Zakine È, et al. Among authors: outh r. J Am Acad Dermatol. 2023 Apr;88(4):917-920. doi: 10.1016/j.jaad.2022.10.052. Epub 2022 Nov 5. J Am Acad Dermatol. 2023. PMID: 36343774 No abstract available.
Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort.
Lefèvre G, Bleuse S, Puyade M, Moulis G, Néel A, Abisror N, Baudet A, Bonnotte B, Dion J, Dossier A, Grall M, Lifermann F, Limal N, Lioger B, Machelart I, Mohr C, Outh R, Queyrel-Moranne V, Slama B, Tréfond L, Abou Chahla W, Ackerman F, Belfeki N, Berezne A, Blade JS, Bouderbala MA, Chebrek S, Cottin V, De Almeida S, De Masson A, Dezoteux F, Goulenok T, Jachiet V, Jouvray M, Latu I, Ledoult E, Leurs A, Lugosi M, Martin M, Melboucy-Belkhir S, Morati-Hafsaoui C, Quemeneur T, Rohmer J, Roy-Peaud F, Sanges S, Schleinitz N, Staumont-Salle D, Taillé C, Terriou L, Tieulie N, Koenga JDE, Schwarb L, Panel K, Kahn JE, Groh M; COHESion study group. Lefèvre G, et al. Among authors: outh r. Allergy. 2025 Apr;80(4):1100-1110. doi: 10.1111/all.16463. Epub 2025 Jan 5. Allergy. 2025. PMID: 39757773
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome.
Breillat P, Carbone F, Lereclus E, Riller Q, d'Izarny-Gargas T, Posseme C, Templé M, Zhao LP, Luka M, Lazaro E Pr, Outh R, Le Guenno G, Lifermann F, Dieudonné Y, Berleur M, Lenormand C, Balabanian K, Weitten T, Guillotin V, Kostine M, Burroni B, Bigot A, Audemard-Verger A, Manuel A, Dossier A, Golden C, Martellosio JP, Faucher B, De Sainte Marie B, Magy-Bertrand N, Lacombe V, Vinzio S, Grosleron S, Dionet L, Tharaux PL, Duffy D, Ménager MM, Dulphy N, Kosmider O, Terrier B. Breillat P, et al. Among authors: outh r. Blood. 2025 Jul 29:blood.2024028216. doi: 10.1182/blood.2024028216. Online ahead of print. Blood. 2025. PMID: 40729686
21 results